MARUCCI ANTHONY S (President & CEO) purchased 40.0% of their position (11.50K shares) of CELLDEX THERAPEUTICS, INC. on the open market
Open‑market purchase worth $308.4K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 11/12/2024ACC: 0001415889-24-026489
DirectorOfficer· President & CEO
Since Jun 2019
+11.50K
Net shares
Net buyer
$308.4K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
11.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+11.50K
Price / share
$26.82
Trade value
$308.43K
% of position
40.0%
11/11/2024
28.78K→40.28K
Total
Net shares
+11.50K
Net value
$308.43K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/11/2024 | P · Purchase | +11.50K | $26.82 | $308.43K | 40.0% | 28.78K | 40.28K |
| Total | +11.50K | $308.43K | ||||||
Derivative Transactions0
No derivative transactions reported